Correlation Between BioLine RX and Clal Biotechnology
Can any of the company-specific risk be diversified away by investing in both BioLine RX and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLine RX and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLine RX and Clal Biotechnology Industries, you can compare the effects of market volatilities on BioLine RX and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLine RX with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLine RX and Clal Biotechnology.
Diversification Opportunities for BioLine RX and Clal Biotechnology
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between BioLine and Clal is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding BioLine RX and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and BioLine RX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLine RX are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of BioLine RX i.e., BioLine RX and Clal Biotechnology go up and down completely randomly.
Pair Corralation between BioLine RX and Clal Biotechnology
Assuming the 90 days trading horizon BioLine RX is expected to under-perform the Clal Biotechnology. In addition to that, BioLine RX is 2.39 times more volatile than Clal Biotechnology Industries. It trades about -0.26 of its total potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.01 per unit of volatility. If you would invest 3,730 in Clal Biotechnology Industries on November 3, 2024 and sell it today you would lose (230.00) from holding Clal Biotechnology Industries or give up 6.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioLine RX vs. Clal Biotechnology Industries
Performance |
| Timeline |
| BioLine RX |
| Clal Biotechnology |
BioLine RX and Clal Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioLine RX and Clal Biotechnology
The main advantage of trading using opposite BioLine RX and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLine RX position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.| BioLine RX vs. Evogene | BioLine RX vs. Enlivex Therapeutics | BioLine RX vs. Kamada | BioLine RX vs. Compugen |
| Clal Biotechnology vs. Kamada | Clal Biotechnology vs. BioLine RX | Clal Biotechnology vs. Evogene | Clal Biotechnology vs. Bezeq Israeli Telecommunication |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |